Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;26(5):319–322. [Article in Spanish] doi: 10.1016/S0212-6567(00)78672-0

Evaluación psicopatológica de pacientes dependientes de cocaína

Psychopathological evaluation of cocaine-dependent patients

E Sánchez Hervás 1,*, V Tomás Gradolí 1, E Morales Gallús 1
PMCID: PMC7675807  PMID: 11100602

Abstract

Objective

To study the presence of psychopathology in patients seeking treatment for cocaine abuse.

Design

Case/control study.

Setting

Addictive conduct unit. Treatment of addiction to legal and illegal drugs. Primary care.

Patients

Patients seeking treatment for cocaine abuse (n = 35). Control group of people with no drug-abuse problems (n = 40).

Measurements and results

Evaluation of psychopathology through the Brief Symptom Inventory (BSI, Derogatis, 1975). Patients who abused cocaine scored high in the BSI, especially in the paranoid ideas (mean = 1.48) and obsessive-compulsive (mean = 1.25) dimensions. When the cocaine group was compared with the control group, there were significant differences in 11 of the 12 indicators. The most relevant significance occurred in the paranoid ideas and psychotic dimensions (p = 0.000).

Conclusions

The high prevalence of psychiatric symptoms in patients seeking cocaineabuse treatment was confirmed. The high scores in the obsessive-compulsive, anxiety and general malaise dimensions hindered the process of treatment in order to stop using the drug, in that the scores drop when consumption stops but start up again intensively in the following days. Given the characteristics of these patients, the BSI seems a useful instrument for guiding the diagnosis and treatment of people who abuse cocaine.

Bibliografía

  • 1.Novick D. The medically in substance abusers. In: Lowinson J.M., editor. Substance abuse. illiams & Wilkins; Baltimore: 1992. [Google Scholar]
  • 2.Gawin F., Kleber H. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arh Gen Psychiatry. 1986;43:107–113. doi: 10.1001/archpsyc.1986.01800020013003. [DOI] [PubMed] [Google Scholar]
  • 3.Gold M., editor. Manifestaciones clínicas de la cocaína. En: Cocaína. Neurociencias; Barcelona: 1993. [Google Scholar]
  • 4.Sorel E. Cocaína, depresión y familia. Psicopatología. 1990;10(4):192–194. [Google Scholar]
  • 5.Nunes E, Quikin F, Rosecan J. Psychiatric diagnosis in cocaine abuse: evidence for biological heterogeneity. Pressented at the British Association for Psychopharmacology, Cambridge, England, el 14 de julio de 1986
  • 6.Gold M. Villar Books; Nueva York: 1989. The good news about panic, ansiety and phobias. [Google Scholar]
  • 7.Post R., Weiss S., Port A. Sensitization and kindling effects of chronic cocaine administration. In: Lakowsky J., Galloway A., White T., editors. Cocaine: pharmacology, physyology and clinical strategies. CRC Press; Boca Raton: 1992. [Google Scholar]
  • 8.Fielman N., Woolfolk R., Allen L. Dimensions of self-concept: a comparison of heroin and cocaine addicts. Am J Drug and Alcohol Abuse. 1995;21(3):315–326. doi: 10.3109/00952999509002700. [DOI] [PubMed] [Google Scholar]
  • 9.Yates W., Fulton A., Gabel J. Factores de riesgo de la personalidad del consumo de cocaína. Rev Esp Toxicomanías. 1995;3:3–5. [Google Scholar]
  • 10.Siegel R. Cocaine smoking. J Psychoactive Drugs. 1982;14:271–359. doi: 10.1080/02791072.1982.10524303. [DOI] [PubMed] [Google Scholar]
  • 11.Catton C., Gralnick A., Bender S. Young chronic patients and substance abuse. Hos Community Psychiatry. 1989;40:1037–1040. doi: 10.1176/ps.40.10.1037. [DOI] [PubMed] [Google Scholar]
  • 12.Havassy B., Arns P. Relationship of cocaine and other substance dependece to well-being of high risk psychiatric patients. Psychiatric Services. 1998;49(7):935–940. doi: 10.1176/ps.49.7.935. [DOI] [PubMed] [Google Scholar]
  • 13.Derogatis L. Clinical Psychometric Research; Baltimore: 1975. Brief symptom inventory. [Google Scholar]
  • 14.Derogatis L. Clinical Psycometric Research; Baltimore: 1983. SCL-90-R. Administration, scoring and procedures manual. [Google Scholar]
  • 15.Derogatis L., Cleary P. Confirmation of the dimensional structure of the SCL-90. A study in construct validation. J Clin Psychology. 1977;33(4):981–989. [Google Scholar]
  • 16.Camí J. Aguilar; Madrid: 1996. Psicoestimulantes. [Google Scholar]
  • 17.Jaffee J. Drug addiction and drug abuse. In: Goldman A.G., Gilman L.J., editors. The pharmacological bases of therapheutics. Macmillan; Nueva York: 1985. pp. 532–581. [Google Scholar]
  • 18.Gawin I., Ellinwood J. Cocaine and other stimulants. N Engl J Med. 1988;318(18):1173–1182. doi: 10.1056/NEJM198805053181806. [DOI] [PubMed] [Google Scholar]
  • 19.Meyer R. How to understand the relationship between psychopathology and addictive disorders. In: Meyer R., editor. Psychoapthology and addictive disorders. Guildorf Press; Nueva York: 1986. [Google Scholar]
  • 20.Robins L., Helzer J., Croughan J. National Institute of Mental Diagnosis Interwiew Schedule. Arch Gen Psychiatry. 1981;38:381–389. doi: 10.1001/archpsyc.1981.01780290015001. [DOI] [PubMed] [Google Scholar]
  • 21.Spitz H., Rosecan J. Neurociencias; Barcelona: 1990. Abuso de cocaína: nuevos enfoques en investigación y tratamiento. [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES